Humacyte, Inc.
Last 30 daysInsiders bought $5.62K · 1 buyer, led by Keith Anthony Jones (Director) with $5.62K. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
$38,580 of common-equity purchase value after transaction-age decay across 180 days.
3 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President, CEO and Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
Director
Common Stock
CFO and Chief Corp. Dev. Off
Common Stock
Chief Medical Officer
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Stock Options (right to buy)Grant or award | Derivative units125,000Award · no purchase price | Non-cash award | Oct 6Filed Oct 7 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units125,000Award · no purchase price | Non-cash award | Oct 6Filed Oct 7 · 1d later | SEC filing |
| Director | Common StockPurchase | 10,000$0.56 / share | $5.62K | Sep 14Filed Sep 15 · 1d later | SEC filing |
| Director | Common StockPurchase | 10,000$0.69 / share | $6.93K | Aug 20Filed Aug 21 · 1d later | SEC filing |
| Director | Common StockPurchase | 30,000$0.59 / share | $17.82K | Aug 17Filed Aug 19 · 2d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| President, CEO and Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units0Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Common StockPurchase | 56,818$0.88 / share | $50K | May 19Filed May 20 · 1d later | SEC filing |
| Director | Common StockPurchase | 11,000$0.89 / share | $9.84K | May 18Filed May 20 · 2d later | SEC filing |
| CFO and Chief Corp. Dev. Off | Common StockSale10b5-1 | 45,887$0.90 / share | $41.15K | May 18Filed May 20 · 2d later | SEC filing |
| Chief Medical Officer | Common StockSale10b5-1 | 45,887$0.90 / share | $41.15K | May 18Filed May 20 · 2d later | SEC filing |
Humacyte, Inc. - Common Stock · Stock
The filing reports a partial sale for a joint account.
Thomas H TubervilleReporting Senate memberHumacyte, Inc. - Common Stock · Stock
The filing reports a full sale for a joint account.
Thomas H TubervilleReporting Senate memberHumacyte Inc · Stock
The filing reports a purchase for a joint account.
Thomas H TubervilleReporting Senate memberHumacyte, Inc. - Common Stock · Stock
The filing reports a purchase for a joint account.
Thomas H TubervilleReporting Senate memberHumacyte, Inc. - Common Stock · Stock
The filing reports a purchase for a joint account.
Thomas H TubervilleReporting Senate member